NATIXIS -2020 Universal Registration Document

GENERAL SHAREHOLDERS’ MEETINGS Terms and conditions of attendance by shareholders at General Shareholders’ Meetings

Identification of shareholders 8.1.5

In line with the provisions of Article 5 of the bylaws, the Company conferring immediately, or in the future, the right to vote at may, subject to the conditions provided for by the laws and Shareholders’ Meetings, notably their identity, nationality, address, regulations in force, request from any authorized organization or the number of shares that they own and the restrictions that may be intermediary, all information relating to the holders of shares placed on these shares.

Disclosure thresholds Any individual or legal entity that directly or indirectly owns, alone or jointly, a 1% share of the voting rights or any multiple of this percentage,must notify the Company, by registered letter with acknowledgementof receipt, of the number of voting rights that they possess. This notice must be made within a period of 15 days following each acquisitionor sale of this fraction.Major holdingnotificationsmust be sent to Natixis’ InvestorRelations (30 avenue Pierre Mendès-France - 75013 Paris). Failure to comply with the notificationrequirement referred to in the previous paragraphshall, at the request of a shareholderowning at least 1% of the voting rights, which request shall be recorded in the minutes of the meeting, cause any shares in excess of the fraction that should have been declared to be stripped of their voting rights for a period of two years following the date on which thewy ere properly reported. Any shareholdersthat hold more than 1% of the voting rights and have already declared that they have crossed the statutorythreshold,may obtainor consult the list of shareholdersthat have crossedthe statutorythresholdof more than 1% at Natixis’ registered office or by contacting Natixis’ Investor Relations (30 avenue Pierre Mendès-France - 75013 Paris).

8

557

www.natixis.com

NATIXIS UNIVERSAL REGISTRATION DOCUMENT 2020